相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
Debora Soncini et al.
HAEMATOLOGICA (2022)
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2022)
Cycloalkane-modified amphiphilic polymers provide direct extraction of membrane proteins for CryoEM analysis (vol 4, 1337, 2021)
Anna J. Higgins et al.
COMMUNICATIONS BIOLOGY (2022)
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Beatrice Eymin
BIOCHEMICAL PHARMACOLOGY (2021)
Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse
Esther Onecha et al.
HAEMATOLOGICA (2021)
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia
Heather C. Murray et al.
LEUKEMIA (2021)
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
Romain Vazquez et al.
BLOOD CANCER JOURNAL (2021)
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma et al.
LEUKEMIA (2021)
Global Proteomic Profiling of Pediatric AML: A Pilot Study
Nam H. K. Nguyen et al.
CANCERS (2021)
Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway
Shaoqing Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
AML: New Drugs but New Challenges
Alan Burnett et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Acute myeloid leukemia transformed to a targetable disease
Khalil Saleh et al.
FUTURE ONCOLOGY (2020)
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia
Elise Aasebo et al.
CANCERS (2020)
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
David G. J. Cucchi et al.
CANCERS (2020)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo et al.
DRUG RESISTANCE UPDATES (2020)
New directions for emerging therapies in acute myeloid leukemia: the next chapter
Naval Daver et al.
BLOOD CANCER JOURNAL (2020)
FOXO1 and ETV6 genes may represent novel regulators of splicing factor expression in cellular senescence
Eva Latorre et al.
FASEB JOURNAL (2019)
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
Esther Onecha et al.
HAEMATOLOGICA (2019)
Management of primary refractory acute myeloid leukemia in the era of targeted therapies
Christine M. McMahon et al.
LEUKEMIA & LYMPHOMA (2019)
Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
May Levin et al.
CELL DEATH & DISEASE (2019)
New drugs approved for acute myeloid leukaemia in 2018
Selin Kucukyurt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B
Xuexia Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
Maria Luz Morales et al.
SCIENTIFIC REPORTS (2019)
Signaling Pathways Driving Aberrant Splicing in Cancer Cells
Vania Goncalves et al.
GENES (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
Proteome-wide identification of ubiquitin interactions using UbIA-MS
Xiaofei Zhang et al.
NATURE PROTOCOLS (2018)
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa ten Hacken et al.
JCI INSIGHT (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
SR Proteins: Binders, Regulators, and Connectors of RNA
Sunjoo Jeong
MOLECULES AND CELLS (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
Alessandro Di Tullio et al.
NATURE COMMUNICATIONS (2017)
A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis
Harold Pimentel et al.
NUCLEIC ACIDS RESEARCH (2016)
Aberrant splicing and drug resistance in AML
Rosalia de Necochea-Campion et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia
Ajay Abraham et al.
PHARMACOGENOMICS (2015)
The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells
Thomas C. Whisenant et al.
PLOS ONE (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
SR proteins control a complex network of RNA-processing events
Todd Bradley et al.
RNA (2015)
A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets
Sophia Adamia et al.
CLINICAL CANCER RESEARCH (2014)
Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib
C. Schaab et al.
LEUKEMIA (2014)
A day in the life of the spliceosome
A. Gregory Matera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Splicing factor SRSF6 promotes hyperplasia of sensitized skin
Mads A. Jensen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells
Vania Goncalves et al.
RNA (2014)
BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells
Xuexia Zhou et al.
NATURE COMMUNICATIONS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
Bob Lowenberg
BLOOD (2013)
Regulation of splicing by SR proteins and SR protein-specific kinases
Zhihong Zhou et al.
CHROMOSOMA (2013)
The splicing factor SRSF6 is amplified and is an oncoprotein inlung and colon cancers
Michal Cohen-Eliav et al.
JOURNAL OF PATHOLOGY (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells
Pedro Casado et al.
SCIENCE SIGNALING (2013)
The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization
S. V. Kozyrev et al.
GENES AND IMMUNITY (2012)
Detecting differential usage of exons from RNA-seq data
Simon Anders et al.
GENOME RESEARCH (2012)
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
Rong Jia et al.
International Journal of Biological Sciences (2012)
Hepatocyte Growth Factor Enhances Alternative Splicing of the Kruppel-like Factor 6 (KLF6) Tumor Suppressor to Promote Growth through SRSF1
Ursula Munoz et al.
MOLECULAR CANCER RESEARCH (2012)
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
V. Visconte et al.
LEUKEMIA (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles
Ryu Miyagawa et al.
RNA (2012)
Side population and cancer stem cells: Therapeutic implications
Lidia Moserle et al.
CANCER LETTERS (2010)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma
Steven Yea et al.
GASTROENTEROLOGY (2008)
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy
Y. Ge et al.
LEUKEMIA (2008)
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a
Sonia Guil et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Rotem Karni et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
ETV6: A versatile player in leukemogenesis
SK Bohlander
SEMINARS IN CANCER BIOLOGY (2005)
Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35 -: Implications for Alzheimer's disease
F Hernández et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
